PW
BSX icon

Paladin Wealth’s Boston Scientific BSX Stock Holding History

Paladin Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Buy
13,099
+6,912
+112% +$375K 0.33% 89
2026
Q1 		$388K Buy
6,187
+149
+2% +$11.9K 0.27% 102
2025
Q4 		$576K Sell
6,038
-745
-11% -$73K 0.39% 86
2025
Q3 		$662K Sell
6,783
-61
-0.9% -$6.32K 0.48% 80
2025
Q2 		$735K Sell
6,844
-312
-4% -$31.6K 0.57% 75
2025
Q1 		$722K Buy
7,156
+113
+2% +$11.4K 0.65% 66
2024
Q4 		$629K Buy
7,043
+45
+0.6% +$3.96K 0.54% 72
2024
Q3 		$586K Buy
+6,998
New +$552K 0.51% 71

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paladin Wealth's BSX Position: Q2 2026 in Review

Paladin Wealth increased its Boston Scientific (BSX) stake by 112% in Q2 2026, buying an estimated $375K and bringing the position to 13,099 shares worth $559K. The position accounts for 0.33% of the portfolio, ranked #89.

Paladin Wealth first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $735K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Paladin Wealth held 13,099 shares of Boston Scientific worth $559K as of Q2 2026.
  • Paladin Wealth bought 6,912 Boston Scientific shares in Q2 2026, an estimated $375K.
  • Boston Scientific made up 0.33% of Paladin Wealth's portfolio in Q2 2026, its #89 holding.
  • Paladin Wealth first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Paladin Wealth's Boston Scientific position peaked at $735K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.